Countries have the right to regulate how biodiversity can be accessed and used, as defined by the United Nations Convention on Biological Diversity (CBD), signed in 1992. The landmark agreement establishes Principles of Access and Benefit Sharing (ABS), including prior informed consent, mutually agreed terms, respect for traditional knowledge and fair and equitable sharing the benefits are obtained.
In 2010, the Nagoya Protocol built upon these ABS principles, clarifying their scope, which now includes research and development (R&D) concerning biochemical components, not just dielectric materials. transmission. The Nagoya Protocol also establishes measures to ensure compliance with ABS principles worldwide. To date, 100 countries have committed to implementing the Nagoya Protocol. Furthermore, the Nagoya Protocol has promoted an increasing number of laws and regulations that establish ABS requirements and outlines allowed systems and sanctions for noncompliance.
ABS rules apply to companies that use biodiversity to develop new products. Laws and regulations around the world increasingly require licenses and agreements for R&D in natural ingredients for food, cosmetics and pharmaceuticals. For example, the EU requires companies to adopt an ABS appraisal system.
UEBT guides and verifies compliance with ABS rules and best practices, incorporated into our standards. In addition, UEBT provides training and consulting services to help companies comply with regulations.